Skip to content
Clinical Trials – home
Centre Hospitalier Universitaire De Lille
Sponsor

Centre Hospitalier Universitaire De Lille

France 2 Avenue Oscar Lambret, Cs 70001, 59037 Lille, France

About the sponsor

Clinical research includes multiple myeloma and acute myeloid leukemia, with interest in CD19-directed cellular therapy, bispecific antibodies, and combinations used in patients with relapsed or newly diagnosed disease.

  • Multiple myeloma
  • Acute myeloid leukemia
  • CAR-T cell therapy
  • CD19-targeted treatment

Work in this area also reflects attention to frail and older patients needing less intensive treatment options.

About Specializations

Centre Hospitalier Universitaire De Lille runs clinical trials in conditions such as Cerebral haemorrhage, Plasma cell myeloma, Hepatitis alcoholic, Chronic obstructive pulmonary disease, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

15 clinical trials

Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Diroximel Fumarate
  • Sponsor:Centre Hospitalier Universitaire De Lille
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Acetylcysteine
  • Sponsor:Centre Hospitalier Universitaire De Lille
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:Centre Hospitalier Universitaire De Lille
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Nivolumab
  • Sponsor:Centre Hospitalier Universitaire De Lille
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Methyl Aminolevulinate
  • Sponsor:Centre Hospitalier Universitaire De Lille
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Cyclophosphamide
  • Sponsor:Centre Hospitalier Universitaire De Lille
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Caffeine
  • Sponsor:Centre Hospitalier Universitaire De Lille
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Exl01
  • Sponsor:Centre Hospitalier Universitaire De Lille
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Centre Hospitalier Universitaire De Lille

Pituitary tumour benign

Not yet recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Fluoroethyltyrosine F-18
  • Sponsor:Centre Hospitalier Universitaire De Lille

Multiple sclerosis+1

Not yet recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Amoxicillin
  • Sponsor:Centre Hospitalier Universitaire De Lille

Lymphatic malformation

Not yet recruiting
Registered drug
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years
  • Substances:Sirolimus
  • Sponsor:Centre Hospitalier Universitaire De Lille

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).